Overview
Mariko Hosozawa practices in Tokyo, Japan. Ms. Hosozawa is rated as an Advanced expert by MediFind in the treatment of Long Haul COVID. Her top areas of expertise are Long Haul COVID, Autism Spectrum Disorder, Severe Acute Respiratory Syndrome (SARS), and COVID-19.
Her clinical research consists of co-authoring 51 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 9 articles in the study of Long Haul COVID.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Autism Spectrum DisorderMs. Hosozawa isAdvanced. Learn about Autism Spectrum Disorder.
- Long Haul COVIDMs. Hosozawa isAdvanced. Learn about Long Haul COVID.
- Severe Acute Respiratory Syndrome (SARS)
- Experienced
- Attention Deficit Hyperactivity Disorder (ADHD)
- COVID-19Ms. Hosozawa isExperienced. Learn about COVID-19.
- Postpartum DepressionMs. Hosozawa isExperienced. Learn about Postpartum Depression.